Schrodinger to offer Eli Lilly's AI drug discovery platform on its software

Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...
TMCnet

Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign

"As a leader in computational drug discovery, Schrödinger is pleased to partner with Lilly TuneLab," stated Pat Lorton, chief technology officer and chief operating officer, software at Schrödinger.

Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities

Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic ...
News.az

Eli Lilly’s AI drug discovery platform joins Schrodinger software

The integration of TuneLab into Schrodinger’s cloud-based LiveDesign platform will provide biotech companies with direct ...